Angelis Oncology, Inc.
Biotech · Regulation D 506(b) · CA · Filed July 23, 2026
View all SEC Form D filings for Angelis Oncology, Inc.- Offering amount
- Undisclosed
- Exemption
- Reg D 506(b)
- Issuer state
- CA
- Filing date
- July 23, 2026
- Signature date
- July 22, 2026
- CIK
- 0002146896
What is a Form D filing?
A Form D is the notice a private company files with the U.S. Securities and Exchange Commission when raising capital through an offering exempt under Regulation D (Rule 506(b), 506(c), or 504). It discloses the offering but is not a solicitation, an endorsement, or a statement of investment merit. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Public filing directories
Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Filing snapshot
Angelis Oncology, Inc. (based in CA) filed SEC Form D on July 23, 2026, disclosing an offering of securities (amount not disclosed) under Rule 506(b) of Regulation D. FormDFlow has tagged the issuer's sector as Biotech. This page reflects the public filing as recorded in SEC EDGAR; see the source document for the complete disclosure.
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.